Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
Xueyin Wang, Mark L. Sandberg, Aaron D. Martin, et al.
Journal of Immunotherapy (2021) Vol. 44, Iss. 8, pp. 292-306
Open Access | Times Cited: 21

Showing 21 citing articles:

Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
Talar Tokatlian, Grace E. Asuelime, Jee‐Young Mock, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003826-e003826
Open Access | Times Cited: 47
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo
Mark L. Sandberg, Xueyin Wang, Aaron D. Martin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 634
Closed Access | Times Cited: 43
Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions
Jiatian Ye, Lan Zheng, Yuedong He, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 23
Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment
Queenie Fernandes, Gulab Sher, Kirti S. Prabhu, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 1-1
Open Access | Times Cited: 7
Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment
Anna Jéssica Duarte Silva, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1354-1354
Open Access | Times Cited: 11
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
Cell chemical biology (2025)
Open Access
Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies
Ziyao Lu, Shahab Haghollahi, Muhammad Zubair Afzal
Cancers (2024) Vol. 16, Iss. 20, pp. 3474-3474
Open Access | Times Cited: 2
Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods
Alexandru Tîrziu, Speranța Avram, Leonard Mada, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 4
Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration
Alice N. Weaver, Wade T. Iams, Jong Chul Park, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1421-1428
Closed Access | Times Cited: 1
NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
Julyun Oh, Charles Kirsh, Jing-Ping Hsin, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109913-109913
Open Access | Times Cited: 1
Unveiling the nexus: The tumor microenvironment as a strategic frontier in viral cancers
Queenie Fernandes, Oginni Gbenga Folorunsho
Cytokine (2024) Vol. 185, pp. 156827-156827
Open Access | Times Cited: 1
A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy
Xueyin Wang, Lu Min Wong, Michele McElvain, et al.
Toxicology and Applied Pharmacology (2022) Vol. 437, pp. 115894-115894
Open Access | Times Cited: 6
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian, Grace E. Asuelime, Martin S. Naradikian, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 1, pp. 58-65
Open Access | Times Cited: 5
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities
Xueyin Wang, Aaron D. Martin, Kathleen R. Negri, et al.
Molecular Immunology (2021) Vol. 138, pp. 137-149
Open Access | Times Cited: 6
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors
Antonio Jimeno, Joaquina Baranda, Wade T. Iams, et al.
Investigational New Drugs (2023) Vol. 41, Iss. 2, pp. 284-295
Open Access | Times Cited: 2
Assessing TCR identity, knock-in efficiency, and potency for individualized TCR-T cell therapy
Julien Camperi, Srinidhi Devarajan, Andy McKay, et al.
Journal of Immunological Methods (2023) Vol. 517, pp. 113491-113491
Closed Access | Times Cited: 2
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”
Ehsan Soleymaninejadian, Paola Zelini, Irene Cassaniti, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 731-731
Open Access | Times Cited: 4
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Data from Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian, Grace E. Asuelime, Martin S. Naradikian, et al.
(2023)
Open Access
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ- PBMC-HPV) in HLA-A*02+ patients with HPV16+ Solid Tumors
Antonio Jimeno, Joaquina Baranda, Wade T. Iams, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top